Treatment and follow-up of children with cerebrotendinous xanthomatosis

[1]  C. Brautbar,et al.  Study of a family with Cerebrotendinous Xanthomatosis. No HLA linkage, but an informative recombination between HLA-B and Bf. , 2008, Tissue antigens.

[2]  A. Tangerman,et al.  Chronic diarrhoea as a dominating symptom in two children with cerebrotendinous xanthomatosis , 1996, Acta paediatrica.

[3]  J. Cruysberg,et al.  Ocular and systemic manifestations of cerebrotendinous xanthomatosis. , 1995, American journal of ophthalmology.

[4]  Y. Friedlander,et al.  Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. , 1994, American journal of human genetics.

[5]  Y. Tokimura,et al.  Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use , 1994, Journal of the Neurological Sciences.

[6]  A. Korczyn,et al.  Magnetic resonance imaging in cerebrotendinous xanthomatosis: A prospective clinical and neuroradiological study , 1994, Journal of the Neurological Sciences.

[7]  J. Cruysberg,et al.  Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. , 1991, American journal of ophthalmology.

[8]  B. Roitberg,et al.  Epileptic Seizure as a Presenting Symptom of Cerebrotendinous Xanthomatosis , 1991, Epilepsia.

[9]  Y. Matsuzawa,et al.  Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. , 1991, Metabolism: clinical and experimental.

[10]  Y. Seyama,et al.  Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of eight patients and review of the literature , 1991, Journal of the Neurological Sciences.

[11]  J. C. van der Molen,et al.  Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. , 1991, Journal of lipid research.

[12]  H. Farpour.  Cataracte zonulaire juvénile et Xanthomatose cérébro-tendineuse , 1990 .

[13]  D. Soffer,et al.  Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis , 1986, Annals of neurology.

[14]  J. C. van der Molen,et al.  Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[15]  C. L. Warner,et al.  Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid , 1985, Annals of neurology.

[16]  L. Scheinberg,et al.  Peripheral neuropathy in cerebrotendinous xanthomatosis. , 1985, Archives of neurology.

[17]  S. Shefer,et al.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.

[18]  C. Cortese,et al.  Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. , 1983, British medical journal.

[19]  J. C. van der Molen,et al.  Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[20]  J. I. Pedersen,et al.  Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors. , 1981, Journal of lipid research.

[21]  H. Farpour,et al.  Familial cerebrotendinous xanthomatosis. Report of a new family and review of the literature. , 1975, Archives of neurology.

[22]  P. Gambert,et al.  Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings. , 1991, Neurology.

[23]  H. Farpour.  [Zonular juvenile cataract and cerebrotendinous xanthomatosis]. , 1990, Klinische Monatsblatter fur Augenheilkunde.